which gained FDA clearance for the treatment of chorea associated with Huntington’s disease (HD) just a week ago. Both companies are aiming to expand into treating Tourette syndrome, which will ...

FND, Sydenham’s Chorea, and PANS/PANDAS On the most basic ... clinicians have labelled this cluster of health problems Metabolic syndrome – which puts people at risk of Type 2 Diabetes and ...

Possibilities such as autoimmune encephalitis like N-methyl D-aspartate (NMDA) encephalitis, Anti phospholipid antibody (APLA) syndrome, neurosarcoidosis ... sequencing and clinical exome sequencing ...

While the specific way INGREZZA works to treat TD and HD chorea is not fully understood, INGREZZA is unique in that it selectively and specifically targets VMAT2 to inhibit the release of dopamine ...

Bartter syndrome is a group of similar rare conditions that affect the kidneys. It's genetic, meaning it's caused by a problem with a gene. If you have this condition, too much salt and calcium ...

What is lower crossed syndrome? If you’ve been told that you have lower crossed syndrome (LCS), you might wonder what this condition is, what causes it, and how it is treated. Lower crossed ...

Chorea is a characteristic type of involuntary movement in Huntington’s disease. This movement is often described as a smooth, writhing, squirmy, or twisting motion. It can affect any part of the body ...

for the treatment of hyperphagia in adults and children 4 years of age and older with Prader-Willi syndrome (PWS). Candel Therapeutics announced final survival data from a phase 2a clinical trial ...

On the contrary, Zesiewicz et al. [53] described a case where levetiracetam induced parkinsonism in a patient treated for Huntington's chorea. This was reversible, and the patient was back to his ...

Choreoathetoid cerebral palsy is a combination of chorea (rapid, jerky movements) and athetosis. This subtype of DCP presents both involuntary movements that are sudden and unpredictable, as well as ...